Cogent Biosciences, Inc.
COGT
Pozycja w akcjach
#3384
Cogent Biosciences, Inc. is a biotechnology firm dedicated to creating targeted... Cogent Biosciences, Inc. is a biotechnology firm dedicated to creating targeted treatments for illnesses rooted in specific genetic anomalies. The company's primary therapeutic candidate is CGT9486, a selective tyrosine kinase inhibitor engineered to block the KIT D816V mutation, a key driver of systemic mastocytosis, along with other KIT exon 17 mutations observed in individuals suffering from advanced gastrointestinal stromal tumors (GIST). Furthermore, Cogent holds a licensing pact with Plexxikon Inc., granting it rights for the investigation, advancement, and marketing of bezuclastinib. Previously known as Unum Therapeutics Inc., the company adopted its current name, Cogent Biosciences, Inc., in October 2020. Established in 2014, Cogent Biosciences is headquartered in Cambridge, Massachusetts.
Cena akcji
$29.79
Kapitalizacja rynkowa
$5.17B
Zmiana (1 dzień)
0.91%
Zmiana (1 rok)
81.75%
Kraj
US
Handel Cogent Biosciences, Inc. (COGT)
Kategoria
Healthcare
EPS dla Cogent Biosciences, Inc. (COGT)
EPS na dzień June 2026 TTM: $-2.31
Według najnowszych raportów finansowych i ceny akcji firmy Cogent Biosciences, Inc., obecny EPS (TTM) wynosi $-2.31. Na koniec roku 2023 firma miała EPS w wysokości $-2.42, wzrost w porównaniu do do EPS z roku 2022, który wynosił $-2.26.
Historia EPS dla Cogent Biosciences, Inc. od 2015 do 2026
EPS na koniec każdego roku
| Rok | EPS | Zmień |
|---|---|---|
| 2026 (TTM) | $-2.31 | -6.10% |
| 2024 | $-2.46 | 1.65% |
| 2023 | $-2.42 | 7.08% |
| 2022 | $-2.26 | 22.16% |
| 2021 | $-1.85 | -69.17% |
| 2020 | $-6.00 | 51.13% |
| 2019 | $-3.97 | -28.47% |
| 2018 | $-5.55 | 60.87% |
| 2017 | $-3.45 | 11.29% |
| 2016 | $-3.10 | 174.34% |
| 2015 | $-1.13 | 0.00% |
EPS dla podobnych firm lub konkurentów
| Firma | EPS | Różnica w EPS | Kraj |
|---|---|---|---|
| $17.32 | -849.78% |
US
|
|
| $-7.98 | 245.45% |
US
|
|
| $-5.29 | 129.00% |
AU
|
|
| - | - |
CH
|
|
| $27.74 | -1,300.87% |
NL
|
